WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that the Company’s President and Chief Executive Officer, Tod Woolf, Ph.D., will present a corporate overview at BioCentury’s 16th Annual Future Leaders in the Biotech Industry Conference on Thursday, April 2, 2009 at 3:00pm ET, at the Millennium Broadway Hotel & Conference Center in New York City.
